Grazax Asthma Prevention

Grazax Asthma Prevention

Investigation of the effect of Grazax (grass tablet) on asthma prevention in children with grass pollen allergy

Investigation of the effect of Grazax (ALK produced grass tablet) on asthma prevention in children with grass pollen allergy.

Children in the age of 6-12 years will be randomised to either placebo or Grazax treatment. Grazax has been approved for treatment of grass pollen allergy in adults and children, diagnosed with a positive skin prick test and/or specific immunoglobulin (IgE) test to grass pollen and with clinically relevant symptoms. This study will explore prevention of asthma in children with grass pollen induced allergy.

Inclusion Criteria:

• A history of grass pollen allergy
• Positive Skin prick test to grass
• Positive specific IgE to grass

Exclusion Criteria:

• Asthma